• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外和体内彗星试验。

The in vitro and in vivo comet assays.

作者信息

Burlinson Brian

机构信息

Safety Assessment, Huntingdon Life Sciences, Woolley Road, Alconbury Huntingdon, Cambridgeshire, PE28 4HS, UK.

出版信息

Methods Mol Biol. 2012;817:143-63. doi: 10.1007/978-1-61779-421-6_8.

DOI:10.1007/978-1-61779-421-6_8
PMID:22147572
Abstract

The strategy for testing for genotoxicity covers three main areas, namely gene mutation, chromosome aberration or breakage (clastogenicity), and chromosome loss or gain (aneuploidy). The current generalized strategy consists of assays capable of detecting all of these endpoints using in vitro assays such as the Ames test for detecting gene mutations in bacteria, the human peripheral lymphocyte chromosome aberration (CA) test for detecting clastogenicity, and the in vitro micronucleus test for clastogenicity and aneuploidy. The primary in vivo assay, and generally the only in vivo assay required, is the in vivo rodent bone marrow micronucleus assay. However, there are instances when these assays alone are inadequate and further testing is required, especially in vivo. Historically, the preferred second assay has been the rodent liver unscheduled DNA synthesis assay but recently this has been superseded by the rodent single cell gel electrophoresis or Comet assay. This assay has numerous advantages especially in vivo, where virtually any tissue can be examined. The status of the in vitro comet assay in regulatory testing is much less clear although a preliminary review of data from the assay has shown it to be more specific than other in vitro genotoxicity tests and less prone to false positives.Detailed here are general protocols for both the in vitro and in vivo comet assays which will form the basis of the pending OECD guideline for the assay.

摘要

遗传毒性检测策略涵盖三个主要领域,即基因突变、染色体畸变或断裂(致断裂性)以及染色体丢失或增加(非整倍体)。当前的通用策略包括一系列检测方法,这些方法能够通过体外试验检测所有这些终点,如用于检测细菌基因突变的艾姆斯试验、用于检测致断裂性的人类外周血淋巴细胞染色体畸变(CA)试验以及用于检测致断裂性和非整倍体的体外微核试验。主要的体内试验,通常也是唯一需要的体内试验,是体内啮齿动物骨髓微核试验。然而,在某些情况下,仅这些试验是不够的,需要进一步检测,尤其是体内检测。从历史上看,首选的第二种试验是啮齿动物肝脏非程序性DNA合成试验,但最近它已被啮齿动物单细胞凝胶电泳或彗星试验所取代。该试验有许多优点,尤其是在体内,几乎可以检查任何组织。体外彗星试验在监管检测中的地位尚不太明确,尽管对该试验数据的初步审查表明它比其他体外遗传毒性试验更具特异性,且不易出现假阳性。这里详细介绍了体外和体内彗星试验的一般方案,这些方案将构成即将出台的经合组织该试验指南的基础。

相似文献

1
The in vitro and in vivo comet assays.体外和体内彗星试验。
Methods Mol Biol. 2012;817:143-63. doi: 10.1007/978-1-61779-421-6_8.
2
Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.体内遗传毒性评估的改进:急性试验的联合应用及整合到标准毒性测试中。
Mutat Res. 2011 Aug 16;723(2):108-20. doi: 10.1016/j.mrgentox.2010.12.005. Epub 2010 Dec 21.
3
Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.致突变性和遗传毒理学中的测试策略:对欧洲化妆品和非食品产品科学委员会染发剂评估指南的评价。
Mutat Res. 2005 Dec 30;588(2):88-105. doi: 10.1016/j.mrgentox.2005.09.006. Epub 2005 Dec 2.
4
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.一组三项体外遗传毒性试验鉴别啮齿类致癌物和非致癌物能力的评估III. 体内的适当后续测试
Mutat Res. 2008 Jul 31;654(2):114-32. doi: 10.1016/j.mrgentox.2008.05.002. Epub 2008 May 16.
5
Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test.评价一种多终点测定方法在大鼠体内的应用,该方法结合了骨髓微核试验、彗星试验和流式细胞术外周血微核试验。
Mutat Res. 2011 May 18;722(1):7-19. doi: 10.1016/j.mrgentox.2011.02.009. Epub 2011 Feb 25.
6
Genetic toxicity of naphthalene: a review.萘的遗传毒性:综述
J Toxicol Environ Health B Crit Rev. 2003 Mar-Apr;6(2):161-83. doi: 10.1080/10937400306472.
7
Experiences with the in vivo and in vitro comet assay in regulatory testing.在法规检测中体内和体外彗星试验的经验。
Mutagenesis. 2015 Jan;30(1):51-7. doi: 10.1093/mutage/geu069.
8
Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.在为期 2 周和 4 周的重复剂量研究中,将大鼠肝彗星试验中的 15 种化合物进行联合研究。
Mutat Res. 2010 Sep 30;702(1):40-69. doi: 10.1016/j.mrgentox.2010.07.006. Epub 2010 Jul 23.
9
Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.遗传毒性评估:运用最佳科学方法进行人体安全性评估 第三部分:彗星试验作为早期药物候选物筛选中体外致断裂性试验的替代方法
Toxicol Sci. 2007 May;97(1):21-6. doi: 10.1093/toxsci/kfl192. Epub 2007 Jan 4.
10
Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.评估 7,12-二甲基苯并(a)蒽或二乙基亚硝胺在 Pig-a、微核和彗星试验中诱导的遗传毒性,这些试验整合到 28 天重复剂量研究中。
Environ Mol Mutagen. 2011 Dec;52(9):711-20. doi: 10.1002/em.20678. Epub 2011 Oct 4.

引用本文的文献

1
Synthetic Diphenylacetylene-Based Retinoids Induce DNA Damage in Chinese Hamster Ovary Cells without Altering Viability.基于二苯乙炔的合成类视黄醇在不改变细胞活力的情况下诱导中国仓鼠卵巢细胞的 DNA 损伤。
Molecules. 2022 Feb 1;27(3):977. doi: 10.3390/molecules27030977.
2
Genotoxicity testing of Persicariae Rhizoma ( H. Gross) aqueous extracts.虎杖(H. Gross)水提取物的遗传毒性测试。
Exp Ther Med. 2016 Jul;12(1):123-134. doi: 10.3892/etm.2016.3273. Epub 2016 Apr 20.
3
An update to the toxicological profile for water-soluble and sparingly soluble tungsten substances.
水溶性和微溶性钨物质毒理学简介的更新
Crit Rev Toxicol. 2015 May;45(5):388-411. doi: 10.3109/10408444.2014.1003422. Epub 2015 Feb 19.
4
A systematic assessment of genotoxicity on pivaloylacylation-7ADCA-a wide existing antibiotic impurity.对新戊酰化7-氨基去乙酰氧基头孢烷酸(一种广泛存在的抗生素杂质)遗传毒性的系统评估。
Int J Clin Exp Med. 2014 Nov 15;7(11):4260-71. eCollection 2014.
5
Antimutagenic compounds and their possible mechanisms of action.抗诱变化合物及其可能的作用机制。
J Appl Genet. 2014 May;55(2):273-85. doi: 10.1007/s13353-014-0198-9. Epub 2014 Mar 11.
6
Comet assay in reconstructed 3D human epidermal skin models--investigation of intra- and inter-laboratory reproducibility with coded chemicals.彗星试验在重建的 3D 人体表皮皮肤模型中的应用——用编码化学品进行的实验室内和实验室间重现性研究。
Mutagenesis. 2013 Nov;28(6):709-20. doi: 10.1093/mutage/get051.
7
Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10.关注驱动的纳米材料测试与评估综合方法——纳米安全集群工作组报告 10 号。
Nanotoxicology. 2014 May;8(3):334-48. doi: 10.3109/17435390.2013.802387. Epub 2013 May 28.
8
The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm-/- mice.BH3 仅家族成员 Bid 的缺失会延迟 Atm-/- 小鼠 T 细胞白血病的发生。
Cell Death Differ. 2013 Jul;20(7):869-77. doi: 10.1038/cdd.2013.16. Epub 2013 Mar 8.
9
Cytosolic Ca2+ shifts as early markers of cytotoxicity.细胞质钙离子变化作为细胞毒性的早期标志物。
Cell Commun Signal. 2013 Feb 6;11(1):11. doi: 10.1186/1478-811X-11-11.